Survival Following the Diagnosis of Noninvasive Bladder Cancer: WHO/International Society of Urological Pathology Versus WHO Classification Systems

Journal of Urology

Volumn 178, Issue 4, 2007, Pages 1196-1200

  Schned, Alan R ^a   Andrew, Angeline S ^a   Marsit, Carmen J ^b   Zens, M Scot ^a   Kelsey, Karl T ^b   Karagas, Margaret R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

epidemiology; pathology; survival; urinary bladder neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; SURVIVAL TIME; WORLD HEALTH ORGANIZATION;

AGED; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEW HAMPSHIRE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SURVIVAL ANALYSIS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 34548456403     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.05.126     Document Type: Article

References (20)

1. Epstein J.I., Amin M.B., Reuter V., and Mostofi F.K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22 (1998) 1435
2. Mostofi F.K., Sobin L.H., and Torloni H. Histological typing of urinary bladder tumours. International Classification of Tumours 19 (1973), World Health Organization, Geneva
3. Holmäng S., Hedelin H., Anderström C., Helmberg E., Busch C., and Johannson S.L. Recurrence and progression in low grade papillary urothelial tumors. J Urol 162 (1999) 702
4. Alsheikh A., Mohamedali Z., Jones E., Masterson J., and Gilks C.B. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. Mod Pathol 14 (2001) 267
5. Holmäng S., Andius P., Hedelin H., Wester K., Busch C., and Johannson S.L. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol 165 (2001) 1124
6. Pich A., Chiusa L., Formiconi A., Galliano D., Bortolini P., and Navone R. Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder. Am J Surg Pathol 25 (2001) 1528
7. Samaratunga H., Makarov D.V., and Epstein J.I. Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology 60 (2002) 315
8. Fujii Y., Kawahomi S., Koga F., Nemoto T., and Kihara K. Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential. BJU Int 92 (2003) 559
9. Montie J.E. Urological oncology: bladder, penis and urethral cancer, and basic principles of oncology. J Urol 173 (2005) 1172
10. Lloreta J., Ferrer L., Serrano S., Amoros A., Puente D., Tardon A., et al. Value of ISUP (1998) and WHO (1999) criteria in the prediction of prognosis in urothelial tumors: a pathological and epidemiological study on a series of 500 primary superficial tumors. Mod Pathol 17 (2004) 164A
11. Campbell P.A., Conrad R.J., Campbell C.M., Nicol D.L., and MacTaggart P. Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome. BJU Int 93 (2004) 1228
12. Krüger S., Thorns C., Bohle A., and Feller A.C. Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder. Int Urol Nephrol 35 (2003) 169
13. Kamel M.H., Daly P.J., Khan M.F., Kay E.W., O'Kelly P., and Hickey D.P. Survival and progression in high grade tumour subset of G2 and G3 pT1 bladder transitional cell carcinoma. Eur J Surg Oncol 32 (2006) 1139
14. Oosterhuis J.W., Schapers R.F., Janssen-Heijnen M.L., Pauwels R.P., Newling D.W., and ten Kate F. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP Classification system and comparison with conventional grading systems. J Clin Pathol 55 (2002) 900
15. Holmäng S., and Johansson S.L. Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system. Urology 66 (2005) 274
16. Karagas M.R., Tosteson T.D., Blum J., Morris J.S., Baron J.A., and Klaue B. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect 106 (1998) 1047
17. Schned A., Schned L., Andrew A., Kelsey K., and Karagas M. Pathologic stage of urinary bladder cancer at presentation in a non-selected patient population in a high-incidence region of the United States. Virchows Archiv 443 (2003) 440
18. Jimenez R.E., Gheiler E., Oskanian P., Tiguert R., Sakr W., Wood D.P., et al. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 24 (2000) 980
19. Haitel A., Posch B., El-Baz M., Mokhtar A.A., Susani M., Ghoneim M.A., et al. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. J Urol 165 (2001) 1481
20. Marsit C.J., Karagas M.R., Andrew A., Liu M., Danaee H., Schned A.R., et al. Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer. Cancer Res 65 (2005) 7081